Evaluating the Risk–Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review

Background: The 2019 coronavirus (COVID-19) outbreak was declared a global pandemic in March 2020. It quickly spread across all continents, causing significant social, environmental, health, and economic impacts. During the pandemic, there has been consideration of repurposing and repositioning of m...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daniel Hsiang-Te Tsai, Emma Harmon, Jan Goelen, Heather E. Barry, Li-Yang Chen, Yingfen Hsia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-08-01
coleção:	Pharmacy
Assuntos:	corticosteroids COVID-19 SARS-CoV-2 randomised clinical trial
Acesso em linha:	https://www.mdpi.com/2226-4787/12/4/129
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!